Imaging Cro Market Outlook 2026-2034: Market Size, Share and Growth Analysis

The Imaging Cro Market is estimated at US$5.8 billion in 2026 and is projected to grow at a CAGR of 7.4% to reach US$10.3 billion by 2034.

Market Overview

The imaging CRO market includes contract research organizations that provide medical imaging services to support clinical trials, translational research, and therapeutic development across pharmaceutical, biotechnology, medical device, and academic programs. Its scope covers imaging protocol design, site qualification, image acquisition oversight, central reading, biomarker analysis, data management, quality control, regulatory documentation, and imaging endpoint support using modalities such as magnetic resonance, computed tomography, ultrasound, nuclear imaging, and digital pathology.

The value chain begins with study design consultation, imaging charter development, site selection, reader training, scan collection, centralized review, data harmonization, and reporting for sponsors and research teams. Major end uses include oncology trials, neurology studies, cardiovascular development, inflammatory disease research, and device validation where imaging serves as a critical endpoint or stratification tool.

Key Companies Analysed

• ICON plc
• IQVIA
• Labcorp Drug Development
• Parexel
• Syneos Health
• Charles River Laboratories
• Medpace
• Pharmaron
• WuXi AppTec
• Evotec
• Premier Research
• ClinChoice
• ProScan Imaging
• Invicro
• BioTelemetry
• Clario
• Calyx
• Bioclinica
• KCR
• Novotech

Geographic Coverage

• North America - Market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - Market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Poland
  • Sweden
  • Russia
  
  
• Asia-Pacific - Market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - Market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - Market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru
  
  

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

• Updated PDF report and an MS Excel workbook containing market tables and figures.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data.
• Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.